In Q4 2023, Elanco Animal Health reported a 5% revenue increase to $1.035 billion, driven by higher prices and demand for farm-animal products.

Elanco Animal Health reported a 5% increase in Q4 2023 revenue to $1.035 billion, driven by increased prices and demand for farm-animal products. Despite a $141 million net loss in Q4, compared to $55 million a year prior, the company's full-year revenue reached $4.417 billion. Elanco aims to achieve adjusted earnings of 25-28 cents per share and revenue of $1.16-1.19 billion for Q1. The company's 2024 guidance projects revenue between $4.45-4.54 billion and an anticipated net loss of $17-62 million.

February 26, 2024
4 Articles

Further Reading